Decoy Therapeutics (DCOY) EBITDA Margin (2016 - 2026)
Decoy Therapeutics' EBITDA Margin was -1149.85% in Q2 2026.
Powered by 
Analysis
Decoy Therapeutics (DCOY) EBITDA Margin (2016 - 2026) Analysis & Trends
On a trailing twelve-month basis, Decoy Therapeutics' EBITDA Margin was -6510.58% through Jun 30, 2026; for FY2021, it was -695.23%, down 546.79 percentage points from FY2020.
- EBITDA Margin shows a five-year change of +3223.88 percentage points (FY2016 to FY2021).
- In earlier years, EBITDA Margin was -148.44% in FY2020 (+86.41 pp), -234.85% in FY2019 (-149.39 pp), -85.46% in FY2018 (+2613.72 pp) and -2699.18% in FY2017 (+1219.93 pp).
- The Q2 2026 figure marks the highest quarterly EBITDA Margin since Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Decoy Therapeutics | 1.23 Mn | 1.23 Mn | - | -1,149.85% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,149.85% |
| Jun 30, 2021 | -544.64% |
| Mar 31, 2021 | -141.85% |
| Dec 31, 2020 | -118.46% |
| Sep 30, 2020 | -127.28% |
| Jun 30, 2020 | -152.55% |
| Mar 31, 2020 | -208.80% |
| Dec 31, 2019 | -197.92% |
| Sep 30, 2019 | -429.27% |
| Jun 30, 2019 | -101.35% |
| Mar 31, 2019 | -216.29% |
| Dec 31, 2018 | -1,236.85% |
| Sep 30, 2018 | -55.55% |
| Jun 30, 2018 | -3,683.78% |
| Mar 31, 2018 | -4,602.23% |
| Dec 31, 2017 | -2,835.28% |
| Sep 30, 2017 | -2,255.80% |
| Jun 30, 2017 | -2,621.94% |
| Mar 31, 2017 | -3,403.42% |
| Dec 31, 2016 | -2,633.76% |
API Access
Decoy Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=DCOY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "DCOY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=DCOY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();